Why Pain Matters
Pain is one of the world's leading causes of disability — and one of its most unequally treated conditions.
Pain decides who works, who learns, who cares for others, and who participates in daily life. This page makes the case with the numbers behind it: how big the burden is, what it takes from people and economies, and why scalable, drug-free relief changes the equation.
The Global Pain Burden
1.71 billion
people worldwide live with musculoskeletal conditions — the leading contributor to disability globally.
619 million
people live with low back pain, the single leading cause of disability — projected to reach 843 million by 2050.
149 million
years lived with disability are attributed to musculoskeletal conditions every year.
Source: Global Burden of Disease study (Institute for Health Metrics and Evaluation), published in The Lancet journals.
"Burden" is not an abstraction. It means function lost: the field not worked, the class not attended, the child not carried, the shift not finished. And the burden is growing fastest in low- and middle-income countries — exactly where pharmacies, clinics, and pain specialists are hardest to reach.
Pain and Work
For most of the world, physical function is income. Pain breaks that link differently depending on where you live:
High-Income Economies
Absenteeism, reduced output, early exit from the workforce. In the United States alone, chronic pain has been estimated to cost $560–635 billion a year in treatment and lost productivity (Institute of Medicine).
Labor-Dependent Economies
Where work is physical and daily, pain converts directly into lost income — a bad back is not a sick day, it is an unpaid day, and often an unfed household.
Informal Economies
No sick leave, no disability coverage, no safety net. Pain is an unmanaged, uninsured risk carried entirely by the person and their family.
And the losses compound:
Pain and Women's Participation
Menstrual and pelvic pain are among the most neglected barriers to education and work worldwide — routinely dismissed, rarely treated, and borne largely in silence. For girls, recurring monthly pain means missed school days that accumulate into missed futures; for women, it means lost wages and interrupted caregiving.
This is a large enough gap that we run a dedicated program on it: Menstrual Pain, Productivity & Education.
Pain, Education, and Health Systems
Education
Pain affects attendance, concentration, and participation — a student in pain is present in body and absent in every way that counts, and the effects accumulate into long-term outcomes.
Health Systems
Unrelieved pain drives repeat visits and demand that overstretched systems in underserved regions cannot absorb — while the underlying need goes unmet between visits.
The Access Gap
The world's default answers to pain — medications, consumables, clinic-based care — all assume infrastructure: a pharmacy in reach, money for refills, a cold chain, a power grid, a clinician nearby. For hundreds of millions of people in low-resource, refugee, and disaster-affected settings, those assumptions fail. The result is not that pain goes untreated by choice; it goes untreated by design.
“The question is not whether the world can treat pain. It is whether relief can reach the people the current system was never built for.”
That is the problem our model answers: reusable, drug-free devices — no batteries, refills, or consumables — deployed through ministries, NGOs, and community health workers, shareable within a household, working for years. The deployment model is the Global Pain Relief Initiative; the published research behind the technology, findings and limitations included, is on Clinical Evidence & Research; and the full argument for treating relief as basic infrastructure is on Pain Relief as Human Infrastructure.
The Case Is Made. The Response Is Ready.
A burden this size doesn't need another awareness campaign — it needs a delivery model that scales. Fund it, partner on it, or put a single device to work.
